Indian pharma receives FDA warning letter for barefoot employees and general 'disrepair'
Following a major recall of eye drop products, India-based pharma Kilitch Healthcare received a warning letter from the FDA noting that multiple employees were working …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.